Weight Loss Program Costing Only +$12,000 Per Year! Who’s going to pay for this because most working Americans can’t?
“About eighty percent of the food on shelves of supermarkets today didn’t exist 100 years ago.”
― Larry McCleary MD
“Industry analysts predict that tirzepatide could become one of the top-selling drugs ever, with annual sales topping $50 billion. It is expected to outpace Novo Nordisk’s Ozempic — a diabetes drug used so commonly to shed pounds that comedian Jimmy Kimmel joked about it at the Oscars.”
Powerful new obesity drug poised to upend weight loss care
By JONEL ALECCIAApril 27, 2023 GMT
As a growing number of overweight Americans clamor for Ozempic and Wegovy — drugs touted by celebrities and on TikTok to pare pounds — an even more powerful obesity medicine is poised to upend treatment.
Tirzepatide, an Eli Lilly and Co. drug approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity lose up to 16% of their body weight, or more than 34 pounds, over nearly 17 months, the company said on Thursday
12ft | New obesity drug Mounjaro poised to surpass Ozempic, Wegovy | AP News
